CD163 and systemic sclerosis: Additionally, the profibrotic phenotype of circulating CD14+ monocytes from SSc-ILD patients was confirmed by the expression of CD163 and boosted secretion of CCL18 and IL-10 in response to pro-inflammatory stimuli (36).